ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1125

Patient Reported Impact of Lupus on Quality of Life

Beth Schneider1, 1MyHealthTeams, San Francisco, CA

Meeting: ACR Convergence 2020

Keywords: Lupus nephritis, Patient reported outcomes

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Patient Outcomes, Preferences, & Attitudes Poster II: Miscellaneous Rheumatic Diseases

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Research was undertaken to better understand how people living with lupus describe its sum total impact on their lives including work, challenges with relationships and its toll on mental health.

Methods: In January 2020 an email invitation to an online survey was sent to US members of MyLupusTeam, a social network of over 171,000 members. In total, 593 members completed the 21-question survey regarding experiences with lupus and impact of the disease on everyday life.

Results: The far-reaching impact on quality of life was evident in that most reported that they found it hard to exercise (85%) and do everyday chores (83%). They also felt that lupus interferes with social life (77%) and disrupts education/work (71%). The emotional toll of lupus manifested in anxiety (72%), depression (70%), feeling isolated/alone (66%) and ensuing challenges in sleeping (79%). Patients reported that the biggest triggers exacerbating lupus symptoms were stress (87%), fatigue (78%), UV exposure (71%) and cold weather (66%). Top two symptoms reported were joint pain/swelling (93%) and fatigue (92%) and these symptoms were considered to be the biggest obstacles to managing lupus (82% pain and 76% fatigue).  While lupus patients had a good understanding of potential lupus symptoms they might experience (75%) and potential triggers (68%), they were less clear on types of medications (58%), exercises (54%) and foods to eat/avoid (48%). The sum total impact of lupus is that only 49% reported that they are able to lead a full life.

Conclusion: Understanding the physical, emotional and quality of life impact of lupus, can help rheumatologists provide a more holistic approach to treating lupus patients. Importantly, by addressing the mental health aspects of lupus, HCPs can help create better health outcomes, including treatment adherence and effective self-care regimens.

Triggers That Worsen Lupus Symptoms

Impact of Lupus on Quality of Life

Emotional Toll of Lupus


Disclosure: B. Schneider, None.

To cite this abstract in AMA style:

Schneider B. Patient Reported Impact of Lupus on Quality of Life [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/patient-reported-impact-of-lupus-on-quality-of-life/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-impact-of-lupus-on-quality-of-life/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology